The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other antibodies are used by physicians to diagnose conditions or by scientists to ...

The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other ...

SOUTH SAN FRANCISCO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Corvus or the Company) (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, today provided a ...

B-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it ...

Treatment of B-cell acute lymphoblastic leukemia has improved thanks to CAR T therapies, but relapse is still very common. An ...

B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most ...

L’infection par le virus Epstein-Barr (EBV) est un prérequis indispensable à la démyélinisation auto-immune du système ...

Une équipe de chercheurs a modifié génétiquement des cellules immunitaires impliquées dans la maladie cœliaque. Leurs résultats donnent l’espoir d’obtenir un traitement encore aujourd’hui inexistant.

Investing.com — TC BioPharm (Holdings) PLC (NASDAQ: TCBP), une entreprise de biotechnologie spécialisée dans les thérapies à base de lymphocytes T gamma-delta, sera retirée du Nasdaq Stock Market aprè ...

The measles virus attacks long-lived immune cells, reducing antibody-mediated protection from other infectious diseases and ...

They also show that models learned from nonsynonymous mutations and from out-of-frame sequences are different, prompting new questions about germinal center function. Strengths of the study include an ...

Chronic lymphocytic leukemia (CLL) affects lymphocytes. Lymphocytes are a type of white blood cell (WBC). CLL specifically affects B lymphocytes ... Experts don’t exactly know what causes ...